NFKB1 and diffuse large B-cell lymphoma: More interesting, NF-κB signaling pathway is activated in EBV-positive DLBCL in both the elderly and nonelderly de novo DLBCL, and it seems to have an impact on the outcome of this patient population [26, 27].